Sign In
Buy NEO
$10.14
+0.0200 (+0.198%)
At Close: Jun 03, 2026
Bull of the Day: NeoGenomics (NEO)
06:46am, Tuesday, 24'th Oct 2023
NeoGenomics ( NEO ) is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat c
NeoGenomics (NEO) Soars 8.9%: Is Further Upside Left in the Stock?
09:46am, Wednesday, 18'th Oct 2023
NeoGenomics (NEO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase
NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023
09:20am, Tuesday, 17'th Oct 2023
FT. MYERS, FL / ACCESSWIRE / October 17, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced that it will report its th
NeoGenomics (NEO) Upgraded to Strong Buy: What Does It Mean for the Stock?
01:31pm, Friday, 13'th Oct 2023
NeoGenomics (NEO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NeoGenomics, Inc (NEO) Q2 2023 Earnings Call Transcript
03:35pm, Tuesday, 08'th Aug 2023
NeoGenomics, Inc (NASDAQ:NEO ) Q2 2023 Earnings Conference Call August 8, 2023 8:30 AM ET Company Participants Kendra Sweeney - Vice President, Investor Relations Chris Smith - Chief Executive Officer
NeoGenomics (NEO) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
12:55pm, Tuesday, 08'th Aug 2023
Although the revenue and EPS for NeoGenomics (NEO) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Stree
NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023
07:10am, Tuesday, 18'th Jul 2023
FT. MYERS, FL / ACCESSWIRE / July 18, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, today announced that it will report its secon
NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference
07:00am, Thursday, 01'st Jun 2023
FT MYERS, FL / ACCESSWIRE / June 1, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced
NeoGenomics: What Lies Ahead
02:00pm, Thursday, 18'th May 2023
Today, we take our first look at NeoGenomics, Inc., a company focused on oncology testing. NeoGenomics has strung together a series of strong quarterly results that has helped the shares double so far
3 Best Breakout Stocks to Invest in for Superlative Returns
08:24am, Tuesday, 16'th May 2023
First Watch Restaurant Group (FWRG), NeoGenomics (NEO), and Universal Stainless & Alloy Products (USAP) have been selected as the breakout stocks for today.
NeoGenomics, Inc. (NEO) Q1 2023 Earnings Call Transcript
08:57pm, Monday, 08'th May 2023
NeoGenomics, Inc. (NASDAQ:NEO ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Kendra Sweeney - VP of IR Chris Smith - CEO Jeff Sherman - CFO Warren Stone - President of
NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates
07:45pm, Monday, 08'th May 2023
NeoGenomics (NEO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.20 per share a year ago.
3 Top Stocks Likely to Exceed Estimates This Earnings Season
08:23am, Friday, 28'th Apr 2023
These top-ranked stocks are likely to beat on the bottom line in their upcoming releases. Tap Portillo's Inc. (PTLO), NeoGenomics (NEO) and Wingstop (WING).
NeoGenomics to Announce First Quarter 2023 Financial Results
07:00am, Monday, 17'th Apr 2023
FT. MYERS, FL / ACCESSWIRE / April 17, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today that it will release its fir
5 Top Stocks Likely to Come Up With Earnings Beat
09:08am, Thursday, 13'th Apr 2023
These top-ranked stocks are likely to beat on the bottom line in their next releases. Tap Lamb Weston (LW), NeoGenomics (NEO), Surrozen (SRZN), KE Hodlings (BEKE) and Insperity (NSP).
